LONDON (AP) — Scientists in Britain say ancient humans may have learned to make fire far earlier than previously believed, after uncovering evidence that deliberate fire-setting took place in what is ...

UC Berkeley Computer Science Professor Sarah Chasins joins WIRED to answer the internet's burning questions about coding. How did programmers code the first ever code? What remnants of the early World ...

Think your Wi-Fi is safe? Your coding tools? Or even your favorite financial apps? This week proves again how hackers, companies, and governments are all locked in a nonstop race to outsmart each ...

Ookla, the company that makes the ubiquitous Speedtest.net Internet speed test, has issued a new report comparing Wi-Fi performance of Apple’s new N1 networking chip in the iPhone 17 against other ...

Billy is a Senior Features Author for Collider. Having written over 300 articles in just over a year, Billy regularly covers the biggest TV shows and films releasing while also analysing some of the ...

A new study has revealed that the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and iPhone Air achieve significantly faster average Wi-Fi speeds compared to the iPhone 16 series, thanks to Apple's ...

A new study led by Carnegie Mellon University's Wood Neuro Research Group takes a more human-centered approach, using advanced brain imaging and a digital visualization tool to illuminate how pain is ...

The title of Pluribus is Latin, usually associated with “E Pluribus Unum" “We want to keep a lot of it secret, and we tried to hit every [sci-fi] trope and turn it on its ear,” Gilligan teased to TV ...

Warning: Spoilers ahead for Apple TV's Pluribus! Pluribus is a new Apple TV series with a strange name and even stranger premise. The sci-fi drama from Breaking Bad and Better Call Saul creator Vince ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Each episode of Pluribus peels the layers of the sudden unification of humanity, slowly explaining ...

GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another long-acting PrEP option this summer, when rival Gilead Sciences rolled out ...